Kv7.2/7.3 channel stimulators (Knopp)

N/A

Report date: 2025/03/20 16:12:59
NME

Base Information

Drug NameKv7.2/7.3 channel stimulators (Knopp)
Drug Alias NameKv7 channel stimulators (Knopp)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium voltage-gated channel subfamily KQT member 3 stimulantsVoltage-gated potassium channel subunit Kv7.2 agonists
TargetsPotassium voltage-gated channel subfamily KQT member 3Voltage-gated potassium channel subunit Kv7.2
Therapy Area/IndicationsNeuralgiaAmyotrophic Lateral SclerosisEpilepsy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKnopp Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesKnopp Biosciences Llc
Inactive CompaniesN/A
Active IndicationsNeuralgiaAmyotrophic Lateral SclerosisEpilepsy +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A